Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports

Ann Intern Med. 2020 Nov 17;173(10):852-853. doi: 10.7326/L20-0681. Epub 2020 Jul 6.

Authors

Douglas E Gladstone¹, Bo Soo Kim², Kathy Mooney¹, Andrew H Karaba², Franco R D'Alessio²

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (D.E.G., K.M.).
² Johns Hopkins University School of Medicine, Baltimore, Maryland (B.S.K., A.H.K., F.R.D.).

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Betacoronavirus
COVID-19
Coronavirus Infections / therapy*
Humans
Immunotherapy / methods*
Male
Middle Aged
Pandemics
Pneumonia, Viral / therapy*
Respiratory Distress Syndrome / therapy*
Respiratory Distress Syndrome / virology
SARS-CoV-2
T-Lymphocytes, Regulatory / physiology*

Grants and funding

T32 AI007291/AI/NIAID NIH HHS/United States